Belite Bio, Inc SEC filings BLTE
Belite Bio, Inc has 214 filings in SEC EDGAR's recent list, going back to Dec 1, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 19, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 30, 2023 | — |
| CORRESP | Letter to the SEC | May 25, 2023 | — |
| UPLOAD | Letter from the SEC | May 25, 2023 | — |
| EFFECT | Filing | May 9, 2023 | — |
| CORRESP | Letter to the SEC | May 5, 2023 | — |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| EFFECT | Filing | Apr 28, 2022 | — |
| EFFECT | Filing | Apr 28, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 28, 2022 | — |
| CORRESP | Letter to the SEC | Apr 25, 2022 | — |
| CORRESP | Letter to the SEC | Apr 25, 2022 | — |
| CERT | Filing | Apr 25, 2022 | — |
| 8-A12B | Filing | Apr 20, 2022 | — |
| CORRESP | Letter to the SEC | Apr 14, 2022 | — |
| CORRESP | Letter to the SEC | Apr 11, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 5, 2022 | — |
| CORRESP | Letter to the SEC | Apr 5, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2022 | — |
| DRSLTR | Filing | Mar 15, 2022 | — |
| DRS/A | Filing | Mar 15, 2022 | — |
| SEC STAFF LETTER | Filing | Feb 14, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2022 | — |
| DRSLTR | Filing | Jan 21, 2022 | — |
| DRS/A | Filing | Jan 21, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2021 | — |
| DRSLTR | Filing | Dec 1, 2021 | — |
| DRS | Filing | Dec 1, 2021 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BLTE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1889109
- Former names
- BELITE BIO, INC (until Oct 30, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.